Grown Rogue International (GRUSF) EPS (Basic) Growth (1y) (2010 - 2025)
Grown Rogue International (GRUSF) EPS (Basic) Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 65.56% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 5.87% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -389.31% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -11.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 105.98% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,385.12% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -15.37% |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 408,607,113.45% |
| Jun 30, 2025 | 120.02% |
| Jan 31, 2023 | 314.92% |
| Jan 31, 2022 | 74.28% |
| Jul 31, 2021 | 95.61% |
| Apr 30, 2021 | 32.64% |
| Jan 31, 2021 | 55.06% |
| Oct 31, 2020 | 100.99% |
| Jul 31, 2020 | 27.94% |
| Apr 30, 2020 | 38.30% |
| Jan 31, 2020 | 71.66% |
| Oct 31, 2019 | 60.83% |
| Jul 31, 2019 | -2,630.50% |
| Apr 30, 2019 | -14,639.63% |
| Jan 31, 2019 | -45,122.22% |
| Feb 28, 2018 | -2,932,023.70% |
| Nov 30, 2017 | 2,938,100.61% |
| Feb 28, 2017 | 210.26% |
| Nov 30, 2016 | 70.78% |
| May 31, 2016 | 103.74% |